Advanced Biomed (ADVB) Other Non-Current Assets (2024 - 2026)
Advanced Biomed (ADVB) posted Other Non-Current Assets of $2184.0 for Q1 2026, up 128.45% sequentially from $956.0 in Q4 2025.
Advanced Biomed (ADVB) Other Non-Current Assets (2024 - 2026) Analysis & Trends
Advanced Biomed has reported Other Non-Current Assets for 2 years, with the latest figure at $2184.0 in Q1 2026.
- Quarterly Other Non-Current Assets changed N/A year-over-year to $2184.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2184.0 (changed N/A YoY) and the FY2025 annual result came in at $2605.0, changed N/A from the prior year.
- Other Non-Current Assets advanced to $2184.0 in Q1 2026 per ADVB's latest filing, from $956.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $74770.0 in Q3 2025 and troughed at $956.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 5.62 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 4.39 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 49.99 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 1.18 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 558.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 567.73 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 576.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 448.88 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 769.30 Mn |
| 10 | Advanced Biomed | 12.28 Mn | 12.28 Mn | - | 2,184.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,184.00 |
| Dec 31, 2025 | 956.00 |
| Sep 30, 2025 | 74,770.00 |
| Jun 30, 2025 | 1.23 Mn |
| Dec 31, 2024 | 672,471.00 |
| Jun 30, 2024 | 638,871.00 |